Abstract
Twenty-two patients, aged 16 to 67, who had malignant gliomas after surgical resection were treated with carmustine and cisplatin intravenous infusion before, during, and after radiotherapy. All patients had subtotal or total resection, or biopsy as the initial procedure. Twenty-one patients who had at least 2 cycles of chemotherapy and finished the whole course of radiotherapy were considered to be evaluable for responses. Among them, 5 had glioblastoma multiforme, 16 had anaplastic astrocytoma. The median time to tumor progression was 35 weeks (range 12-130 weeks) and median survival time was 66 weeks (range 10-156 weeks). Early progression occurred more frequently in patients with biopsy only and subtotal resection, and in patients with glioblastoma than in those with anaplastic astrocytoma. This combined modality treatment program was associated with reversible hematologic toxicity which was severe in 2 patients, and with ototoxicity in 1 patient, nephrotoxicity in 2 patients. Combination of carmustine and cisplatin with cranial irradiation for malignant gliomas is moderately toxic and appears to offer no obvious survival advantage compared with radiation therapy plus BCNU alone.
References
Jan 1, 1978·Acta Radiologica: Oncology, Radiation, Physics, Biology·A P Andersen
Sep 1, 1978·Journal of Neurosurgery·M D WalkerT A Strike
Aug 1, 1978·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Jul 1, 1992·Journal of Neuro-oncology·H C Wang, Y S Ho
Feb 1, 1992·Journal of Neuro-oncology·W K YungL G Feun
Apr 1, 1990·American Journal of Clinical Oncology·L RechtJ Greenberger
Dec 1, 1985·Journal of Neurosurgery·F H HochbergK Davis
May 1, 1988·Magnetic Resonance Imaging·L M ToonkelJ Sheldon
Apr 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·E FreiW A Haseltine
Jan 1, 1983·Journal of Neuro-oncology·L G FeunR S Benjamin
Feb 15, 1981·Cancer·K KristiansenK Elgen
Sep 15, 1983·Cancer·C H ChangY Tsukada
Jan 1, 1984·Biochimica Et Biophysica Acta·A S Bellamy, B T Hill
Dec 1, 1983·Cancer·J C AllenB Jereb
Dec 4, 1980·The New England Journal of Medicine·M D WalkerT A Strike
Jul 1, 1981·Journal of Neurosurgery
Jul 1, 1980·International Journal of Radiation Oncology, Biology, Physics·R J Berry